6
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Malignant Histiocytosis (Histiocytic Sarcoma) A (The?) Major Cause of the 'Midline Granuloma Syndrome'

, &
Pages 135-145 | Published online: 08 Jul 2009

References

  • Friedmann I, Osborn DA. Pathology of Granulomas and Neoplasms of the Nose and Paranasal Sinuses. Churchill Livingstone, Edinburgh-London 1982
  • Eichel B S, Mabery TE. The enigma of the lethal midline granuloma. Laryngoscope. St. Louisxb 1968; 78: 1367–1370
  • McGuirt W F, Rose EF. Lethal midline granuloma: a pathological spectrum. J Laryngol Otol 1976; 90: 459–466
  • Stewart JP. Progressive lethal granulomatous ulceration of the nose. J Laryngol Otol 1933; 48: 657–701
  • Friedmann I. The changing pattern of granulomas of the upper respiratory tract. J Laryngol Otol 1971; 85: 631–682
  • Kassel S H, Echevaria R A, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 1969; 23: 920–935
  • Fechner R E, Lamppin DW. Midline reticulosis. A clinicopathologic entity. Arch Otolaryngol 1973; 95: 467–476
  • Eichel B S, Harrison E GJ, Devine K D, Scanlon P W, Brown HA. Primary lymphoma of the nose including relationship to lethal midline granuloma. Am J Surg 1966; 112: 597–605
  • Schlegel R, Kraft R. Midline granuloma. HNO 1979; 27: 334–344
  • Aozasa K, Watanabe Y, Ideka H. Malignant histiocytosis presenting as lethal midline granuloma. Path Res Pract 1981; 171: 314–324.
  • Aozasa K, Inoue A. Malignant histiocytosis presenting as lethal midline granuloma: Immunohis-tological study. J Pathology 1982; 138: 241–249
  • Aozasa K. Biopsy findings in malignant histiocytosis presenting as lethal midline granuloma. J Clin Pathol 1982; 35: 599–605
  • Mueller J, Bran del Re G, Buerki H, Keller H U, Hess M W, Cottier H. Nonspecific acid esterase activity: a criterion for differentiation of T and B lymphocytes in mouse lymph nodes. Eur J Immunol 1975; 5: 270–274
  • Lojda Z, van der Ploeg M, van Duijn P. Phosphates of the naphthol AS series in the quantitative determination of alkaline and acid phosphatase activities “in situ” studied in polyacrylamide membrane model systems and by cytospectrophotometry. Histochemie 1967; 11: 13–32
  • Hayashi M. Distribution of β-glucuronidase activity in rat tissues employing the naphthol AS-BI glucuronide hexazonium pararosanilin method. J Histochem Cytochem 1964; 12: 659–669
  • Leder LD. Über die selektive fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewebsmastzellen im Paraffinschnitt. Klin Wschr 1964; 42: 553
  • Järvinen M, Rinne A. The use of polyvinyl acetate glue to prevent detachment of tissue sections in immunohistochemistry. Acta Histochem 1983; 72: 251–252
  • Hsu S M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxi-dase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–580
  • Walton EW. Non-healing granulomata of the nose. J Laryngol Otol 1959; 73: 242–260
  • Michaels L, Gregory MM. Pathology of “non-healing (midline) granuloma”. J Clin Pathol 1977; 30: 317–327
  • Aozasa K. Villous atrophy with crypt hyperplasia in malignant histiocytosis of the nose. J Clin Pathol 1982; 35: 606–610
  • Mann W J, Riede U NB, Öcking A. Midline malignant reticulosis. Acta Otolaryngol (Stockh) 1984; 97: 365–372
  • Kindblom L G, Jacobsen G K, Jacobsen M. Immunohistochemical investigations of tumors of supposed fibroblastic-histiocytic origin. Hum Pathol 1982; 13: 834–840
  • Isaacson PG, Jones DB. Immunohistochemical differentiation between histiocytic and lymphoid neoplasms. Histochem J 1983; 15: 621–635
  • Isaacson P, Wright D H, Jones DB. Malignant lymphoma of true histiocytic (monocyte/macrophage) origin. Cancer 1983; 51: 80–91
  • Du Boulay C EH. Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous histiocytomas using the immunoperoxidase technique. Am J Surg Pathol 1982; 6: 559–564
  • Meister P. Immunohistochemische Methoden bei der Diagnostik von Weichgewebstumoren. Pathologe 1984; 5: 90–98
  • Li C Y, Lam K W, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973; 21: 1–12
  • van der Valk Pte, Velde J, Jansen J, Ruiter D J, Spaander P J, Cornelisse C J, Meijer C JLM. Malignant lymphoma of true histiocytic origin: Histiocytic sarcoma. Virchows Arch (Pathol Anat) 1981; 391: 249–265
  • Ducatman B S, Wick M R, Morgan T W, Banks P M, Pierre RV. Malignant histiocytosis: a clinical, histologic, and immunohistochemical study of 20 cases. Hum Pathol 1984; 15: 368–377
  • van Heerde P, Feltkamp C A, Feltkamp-Vroom T M, Koudstaal J. Sarcoma arising from interdigi-tating cells. Cytology and cytochemistry. Acta Cytologica 1983; 27: 306–312
  • Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, Takeda I, Akagi T. Immunohistochemical localization and distribution of S-100 proteins in the human lymphoreticular system. Am J Pathol 1984; 116: 497–503
  • Tubbs R R, Fishleder A, Weiss R A, Savage R A, Sebek B A, Weick JK. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Am J Pathol 1983; 113: 207–221
  • Haubenstock A, Base W, Bettelheim P, Hinterberger W, Pavelka M, Thaler E, Radaszkiewicz T, Neumann E, Schnedl W, Majdic O, Lechner K. Malignant histiocytosis with unusual features. Cancer 1984; 53: 1574–1578
  • Vera R, Bertino J R, Cadman E, Waldron JA. Malignant histiocytosis. Response to VP-16–213 and cytosine arabinoside. Cancer 1984; 54: 991–993
  • Robins H I, Aubuchon J P, Hafez G R, Bozdech M J, Steeves R, Davis TE. Late recurrences of histiocytic lymphoma after treatment. Cancer 1984; 53: 2663–2667

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.